Literature DB >> 17339482

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.

Matti Laine1, Hanna Jarva, Sanna Seitsonen, Karita Haapasalo, Markus J Lehtinen, Nina Lindeman, Don H Anderson, Patrick T Johnson, Irma Järvelä, T Sakari Jokiranta, Gregory S Hageman, Ilkka Immonen, Seppo Meri.   

Abstract

Complement factor H (FH) is an important regulator of the alternative complement pathway. The Y402H polymorphism within the seventh short consensus repeat of FH was recently shown to be associated with age-related macular degeneration, the most common cause of irreversible blindness in the Western world. We examined the effects of this polymorphism on various FH functions. FH purified from sera of age-related macular degeneration patients homozygous for the FH(402H) variant showed a significantly reduced binding to C-reactive protein (CRP), an acute phase protein, as compared with FH derived from unaffected controls homozygous for the FH(402Y) variant. Strongly reduced binding to CRP was also observed with a recombinant fragment of FH (short consensus repeat 5-7) containing the same amino acid change. Because the interaction of CRP and FH promotes complement-mediated clearance of cellular debris in a noninflammatory fashion, we propose that the reduced binding of FH(402H) to CRP could lead to an impaired targeting of FH to cellular debris and a reduction in debris clearance and enhanced inflammation along the macular retinal pigmented epithelium-choroid interface in individuals with age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339482      PMCID: PMC4853917          DOI: 10.4049/jimmunol.178.6.3831

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Regulation of complement activation by C-reactive protein.

Authors:  C Mold; H Gewurz; T W Du Clos
Journal:  Immunopharmacology       Date:  1999-05

2.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

3.  A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.

Authors:  Eleni Giannakis; T Sakari Jokiranta; Dean A Male; Shoba Ranganathan; Rebecca J Ormsby; Vince A Fischetti; Carolyn Mold; David L Gordon
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  Interdomain contact regions and angles between adjacent short consensus repeat domains.

Authors:  Markus J Lehtinen; Seppo Meri; T Sakari Jokiranta
Journal:  J Mol Biol       Date:  2004-12-10       Impact factor: 5.469

5.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

6.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

8.  C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles.

Authors:  Sanna Taskinen; Marja Hyvönen; Petri T Kovanen; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

Review 9.  C-reactive protein and the acute phase response.

Authors:  H Gewurz; C Mold; J Siegel; B Fiedel
Journal:  Adv Intern Med       Date:  1982

Review 10.  A role for local inflammation in the formation of drusen in the aging eye.

Authors:  Don H Anderson; Robert F Mullins; Gregory S Hageman; Lincoln V Johnson
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

View more
  112 in total

1.  Lack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation.

Authors:  Riikka Tulamo; Juhana Frösen; Anders Paetau; Sanna Seitsonen; Juha Hernesniemi; Mika Niemelä; Irma Järvelä; Seppo Meri
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 2.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 3.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 4.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

Review 5.  Complement pathway biomarkers and age-related macular degeneration.

Authors:  M Gemenetzi; A J Lotery
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

6.  Association between vitamin D status and age-related macular degeneration by genetic risk.

Authors:  Amy E Millen; Kristin J Meyers; Zhe Liu; Corinne D Engelman; Robert B Wallace; Erin S LeBlanc; Lesley F Tinker; Sudha K Iyengar; Jennifer G Robinson; Gloria E Sarto; Julie A Mares
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

7.  Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study.

Authors:  J Jylhävä; C Eklund; T Pessi; O T Raitakari; M Juonala; M Kähönen; J S A Viikari; T Lehtimäki; M Hurme
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 8.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 9.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

Review 10.  The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.

Authors:  Don H Anderson; Monte J Radeke; Natasha B Gallo; Ethan A Chapin; Patrick T Johnson; Christy R Curletti; Lisa S Hancox; Jane Hu; Jessica N Ebright; Goldis Malek; Michael A Hauser; Catherine Bowes Rickman; Dean Bok; Gregory S Hageman; Lincoln V Johnson
Journal:  Prog Retin Eye Res       Date:  2009-12-02       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.